$178M Verdict Against Novartis Stands But Can't Be Tripled
A California federal judge has upheld a jury's $177.8 million infringement verdict against Novartis but overturned the jury's finding that the infringement of a Daiichi Sankyo unit's patents was willful....To view the full article, register now.
Already a subscriber? Click here to view full article